Leonard S. Jacob is Director at ANTARES PHARMA, INC. (ATRS). They have made 24 open-market trades across 3 companies since 2007, most recently 2022-05-24.
CIK 0001049713
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
13 open-market purchases totalling $192K since 2007, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ATRS | SELL | 2021-02-18 | 2021-02-19 | $5.05 | $155K | -10.5% | -10.9% | -14.5% |
| ATRS | SELL | 2019-12-09 | 2019-12-11 | $4.63 | $1.5M | +0.4% | -6.3% | -34.5% |
| ATRS | SELL | 2019-04-08 | 2019-04-10 | $3.00 | $276K | -3.4% | -0.3% | +14.7% |
| ATRS | SELL | 2019-04-08 | 2019-04-10 | $3.00 | $276K | -3.4% | -0.3% | +14.7% |
| ATRS | SELL | 2017-10-09 | 2017-10-11 | $4.05 | $810K | -43.5% | -52.9% | -44.2% |
| ATRS | SELL | 2017-10-09 | 2017-10-11 | $4.05 | $932K | -43.5% | -52.9% | -44.2% |
| ATRS | SELL | 2017-04-04 | 2017-04-05 | $2.90 | $63K | -8.7% | +0.3% | +4.7% |
| ATRS | SELL | 2017-04-03 | 2017-04-05 | $2.88 | $58K | -8.7% | +0.3% | +4.7% |
| ATRS | SELL | 2017-04-03 | 2017-04-05 | $2.89 | $184K | -8.7% | +0.3% | +4.7% |
| ATRS | SELL · 10b5-1 | 2016-12-01 | 2016-12-05 | $1.97 | $39K | +4.4% | +13.1% | +20.4% |
| ATRS | BUY | 2016-03-18 | 2016-03-21 | $0.72 | $36K | +10.9% | +8.3% | +25.6% |
| ATRS | SELL | 2015-03-20 | 2015-03-24 | $2.68 | $63K | -22.0% | -2.5% | -2.5% |
| ATRS | BUY | 2014-08-11 | 2014-08-12 | $1.98 | $20K | -22.0% | -2.5% | -2.5% |
| ATRS | SELL · 10b5-1 | 2014-01-15 | 2014-01-17 | $5.05 | $58K | -22.0% | -2.5% | -2.5% |
| ATRS | SELL | 2013-05-17 | 2013-05-21 | $4.00 | $68K | -22.0% | -2.5% | -2.5% |
| ATRS | BUY | 2012-11-16 | 2012-11-16 | $3.44 | $34K | -22.0% | -2.5% | -2.5% |
| AIS | BUY | 2011-12-22 | 2011-12-22 | $1.79 | $9K | N/A | N/A | N/A |
| AIS | BUY | 2011-08-12 | 2011-08-15 | $2.06 | $4K | N/A | N/A | N/A |
| AIS | BUY | 2011-04-13 | 2011-04-14 | $1.58 | $16K | N/A | N/A | N/A |
| AIS | BUY | 2010-08-16 | 2010-08-17 | $1.59 | $8K | N/A | N/A | N/A |
| AIS | BUY | 2010-03-26 | 2010-03-29 | $1.45 | $7K | N/A | N/A | N/A |
| AIS | BUY | 2009-12-15 | 2009-12-16 | $1.07 | $5K | N/A | N/A | N/A |
| AIS | BUY | 2008-11-17 | 2008-11-19 | $0.48 | $10K | N/A | N/A | N/A |
| AIS | BUY | 2007-11-19 | 2007-11-20 | $1.09 | $11K | N/A | N/A | N/A |
| AIS | BUY | 2007-08-20 | 2007-08-22 | $1.29 | $13K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.